Evidence map›Paper›PMID 36228916›Full record

ArticleThe American journal of tropical medicine and hygiene2022

East Africa International Center of Excellence for Malaria Research: Summary of Key Research Findings.

Joaniter I Nankabirwa, John Rek, Emmanuel Arinaitwe, Jane Frances Namuganga, Sam L Nsobya, Victor Asua, Henry D Mawejje, Adrienne Epstein, Bryan Greenhouse, Isabel Rodriguez-Barraquer and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 4 countries.

Joaniter I NankabirwaInfectious Diseases Research Collaboration, Kampala, Uganda.
John RekInfectious Diseases Research Collaboration, Kampala, Uganda.
Emmanuel ArinaitweInfectious Diseases Research Collaboration, Kampala, Uganda.
Jane Frances NamugangaInfectious Diseases Research Collaboration, Kampala, Uganda.
Sam L NsobyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Victor AsuaInfectious Diseases Research Collaboration, Kampala, Uganda.
Henry D MawejjeInfectious Diseases Research Collaboration, Kampala, Uganda.
Adrienne EpsteinDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
Bryan GreenhouseDepartment of Medicine, University of California San Francisco, San Francisco, California.
Isabel Rodriguez-BarraquerDepartment of Medicine, University of California San Francisco, San Francisco, California.
Jessica BriggsDepartment of Medicine, University of California San Francisco, San Francisco, California.
Paul J KrezanoskiDepartment of Medicine, University of California San Francisco, San Francisco, California.
Philip J RosenthalDepartment of Medicine, University of California San Francisco, San Francisco, California.
Melissa ConradDepartment of Medicine, University of California San Francisco, San Francisco, California.
David SmithInstitute for Health Metrics & Evaluation, University of Washington, Seattle, Washington.
Sarah G StaedkeDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Chris DrakeleyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Teun BousemaDepartment of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Chiara AndolinaDepartment of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Martin J DonnellyDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Grant DorseyDepartment of Medicine, University of California San Francisco, San Francisco, California.
University of California, San Francisco · USInfectious Diseases Research Collaboration · UGLondon School of Hygiene & Tropical Medicine · GBInstitute for Health Metrics and Evaluation · USLiverpool School of Tropical Medicine · GBMakerere University · UGRadboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

Transmission ProjectU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2010 to 2026
$29.3M
Training in malaria surveillance, epidemiology and implementation science research to strengthen malaria policy and control in UgandaD43TW010526 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI MATTHEW G DORSEY, MOSES Robert KAMYA · 2017 to 2026
$2.3M
Mentoring translational scientists in international infectious disease researchK24AI144048 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bryan R Greenhouse · 2019 to 2026
$1.6M
Identifying gaps between LLIN use and vector exposure to improve malaria controlK23AI139364 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KREZANOSKI, PAUL JOSEPH · 2019 to 2023
$986k
Improving the accuracy of malaria surveillance with serology and parasite genetic dataK23AI166009 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jessica Briggs · 2022 to 2026
$955k
Translational Studies of Plasmodium Falciparum Infection DynamicsK23AI076614 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENHOUSE, BRYAN R · 2008 to 2012
$609k
Impact of malaria control interventions on the infectious reservoir, host immunity, and drug resistance in UgandaK43TW010365 · FIC · INFECTIOUS DISEASES RES COLLABORATION · PI NANKABIRWA, JOANITER IMMACULATE · 2017 to 2021
$514k
FIC NIH HHS D43 TW010526FIC NIH HHS K43 TW010365NIAID NIH HHS K23 AI076614NIAID NIH HHS K23 AI139364NIAID NIH HHS K23 AI166009NIAID NIH HHS K24 AI144048NIAID NIH HHS U19 AI089674
6 · The paper itself

Abstract

The Program for Resistance, Immunology, Surveillance, and Modeling of Malaria (PRISM) has been conducting malaria research in Uganda since 2010 to improve the understanding of the disease and measure the impact of population-level control interventions in the country. Here, we will summarize key research findings from a series of studies addressing routine health facility-based surveillance, comprehensive cohort studies, studies of the molecular epidemiology, and transmission of malaria, evaluation of antimalarial drug efficacy, and resistance across the country, and assessments of insecticide resistance. Among our key findings are the following. First, we found that in historically high transmission areas of Uganda, a combination of universal distribution of long-lasting insecticidal-treated nets (LLINs) and sustained indoor residual spraying (IRS) of insecticides lowered the malaria burden greatly, but marked resurgences occurred if IRS was discontinued. Second, submicroscopic infections are common and key drivers of malaria transmission, especially in school-age children (5-15 years). Third, markers of drug resistance have changed over time, with new concerning emergence of markers predicting resistance to artemisinin antimalarials. Fourth, insecticide resistance monitoring has demonstrated high levels of resistance to pyrethroids, appreciable impact of the synergist piperonyl butoxide to pyrethroid susceptibility, emerging resistance to carbamates, and complete susceptibility of malaria vectors to organophosphates, which could have important implications for vector control interventions. Overall, PRISM has yielded a wealth of information informing researchers and policy-makers on the malaria burden and opportunities for improved malaria control and eventual elimination in Uganda. Continued studies concerning all the types of surveillance discussed above are ongoing.

Indexed as

AntimalarialsArtemisininsInsecticidesInsecticide-Treated BednetsMalariaPyrethrinsAdolescentAnimalsCarbamatesChildChild, PreschoolHumansInsecticide ResistanceMosquito ControlMosquito VectorsOrganophosphatesAntimalarialsArtemisininsCarbamatesInsecticidesOrganophosphatesPiperonyl ButoxidePyrethrins

Identifiers

PMID36228916
PMCPMC9662228
OpenAlexW4306154006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.